Home
Aptus Pharma Ltd Share Price History
BSE : 30 Sep, 2025
84.8414.8 (21.2%)
Prev Close
70.0
Open Price
80.8
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
838000
Today's High / Low
84.8 / 80.8
52 WK High / Low
84.8 / 80.8
Market Price of Aptus Pharma Ltd
1M
1Y
3Y
5Y
Monitoring Aptus Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2023 |
|---|---|
| Sales (Cr.) | 14 |
| Sales YoY Gr. | - |
| Adj EPS | 6.48 |
| YoY Gr. | - |
| Net Profit (Cr.) | 0 |
| BVPS | 32.28 |
Key Financial Parameters
| Parameter | 2023 |
|---|---|
| Return on Capital Emp. % | 13.07 |
| Op. Profit Mgn % | 4.46 |
| Net Profit Mgn % | 1.37 |
| Debt to Equity % | 2.28 |
Latest Shareholding
Promoters Holdings Over Time
About Aptus Pharma Ltd
- Aptus Pharma Limited was originally incorporated as 'Aptus Pharma Private Limited', as a private limited company with the Registrar of Companies, Gujarat, pursuant to a Certificate of Incorporation dated August 12, 2010.
- Subsequently, Company was converted into a public limited retaining the name as 'Aptus Pharma Limited' and a fresh certificate of incorporation dated December 12, 2024 was issued by the Registrar of Companies, Central Processing Centre. Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations.
- While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model with 7 units. under various arrangements.
- It provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products.
Popular Search
FAQs for null Share Price History
What are the key events that typically impact Aptus Pharma Ltd's share price history?
Key events that impact Aptus Pharma Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Aptus Pharma Ltd's share price history?
Stock splits reduce the nominal price of Aptus Pharma Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Aptus Pharma Ltd?
Dividends can influence Aptus Pharma Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Aptus Pharma Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Aptus Pharma Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Aptus Pharma Ltd’s share price history?
To understand Aptus Pharma Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
